We would love for you to become a part of our community. Join our Discord to connect with us and other members!

Ticker
BAYNN.MX

Price
-
Stock movement down
-18.20 (-3.25%)
Company name
Bayer Aktiengesellschaft
Exchange
(MX
,
Currency
MXN
)
Markedsverdi
532.28B
Ent verdi
609.55B
Pris/omsetning
11.17
Pris/bok
16.09
Utbytte avkastning
-
Utbytte vekst
-
Vekst år
-
FCF-utbetaling
200.30%
Etterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
-
1 års avkastning
-52.53%
3 års avkastning
-24.76%
5 års avkastning
-16.35%
10 års avkastning
-11.41%
Sist oppdatert: 2024-12-17

UTBYTTE

BAYNN.MX betaler ikke utbytte

VERDSETTELSE

Verdsettelsesforhold

Loading...
Verdsettelsesforhold-data
Etterfølgende P/E-
Pris til OCF104.02
Pris til FCF224.97
Pris til EBITDA208.16
EV i forhold til EBITDA238.39

Verdsettelse (Salg/Bokført verdi)

Loading...
Verdsettelse (Salg/Bokført verdi) data
Pris til omsetning11.17
Pris til bok16.09
EV i forhold til salg12.80

ØKONOMI

Per aksje

Loading...
Per aksje-data
Gjeldende aksje antall982.42M
EPS (TTM)-2.99
FCF per aksje (TTM)2.41

Resultatregnskap

Loading...
Resultatregnskap-data
Inntekter (TTM)47.64B
Bruttofortjeneste (TTM)27.89B
Driftsinntekter (TTM)8.04B
Netto inntekt (TTM)-2.94B
EPS (TTM)-2.99
EPS (1 år fremover)-

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)58.54%
Driftsmargin (TTM)16.87%
Fortjenestemargin (TTM)-6.17%

Balanse

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
Kontanter5.91B
Netto fordringer9.34B
Samlede omløpsmidler37.56B
Goodwill32.30B
Immaterielle eiendeler23.36B
Eiendom, anlegg og utstyr29.26B
Sum eiendeler116.26B
Leverandørgjeld7.46B
Kortsiktig/nåværende langsiktig gjeld0.00
Sum kortsiktig gjeld29.46B
Sum gjeld83.18B
Aksjonærenes egenkapital33.08B
Netto varige driftsmidler0.00

Kontantstrøm

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
Kontantstrøm fra drift (TTM)5.12B
Kapitalutgifter (TTM)2.89B
Fri kontantstrøm (TTM)2.37B
Utbetalt utbytte (TTM)4.74B

Finansielle inntekter

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
Egenkapitalavkastning-8.89%
Avkastning på eiendeler-2.53%
Avkastning på investert kapital-4.18%
Kontantavkastning på investert kapital3.37%

AKSJEINFORMASJON

Nedsidepotensial

Loading...
Nedsidepotensial-data
BAYNN.MXS&P500
Nåværende prisfall fra toppnotering-79.41%-0.42%
Høyeste prisfall-79.41%-56.47%
Dato for høyeste fall1 Feb 20249 Mar 2009
Gj.snittlig fall fra topp-32.11%-11.13%
Gj.snittlig tid til ny topp28 days12 days
Maks tid til ny topp1577 days1805 days
SELSKAPSOPPLYSNINGER
BAYNN.MX (Bayer Aktiengesellschaft) company logo
Markedsverdi
532.28B
Markedsverdi kategori
Large-cap
Beskrivelse
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen
Ansatte
96931
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
Mexico
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
Ingen gjenstander funnet